Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Michelia velutina DC. Prodr.

ABSTRACT: Michelia of Magnoliaceae Genome sequencing and assembly

PROVIDER: PRJNA948545 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23985292_1.fastq.gz	Fastqsanger.gz
	SRR23985292_2.fastq.gz	Fastqsanger.gz
	SRR24656506_1.fastq.gz	Fastqsanger.gz
	SRR24656506_2.fastq.gz	Fastqsanger.gz
	SRR25033716_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Magnoliaceae

Project description:Magnoliaceae Genome sequencing and assembly

| PRJNA770098 | ENA

Magnoliaceae

Project description:Magnoliaceae Genome sequencing

| PRJEB84396 | ENA

Magnoliaceae

Project description:Magnoliaceae Genome sequencing

| PRJNA1166870 | ENA

Vespa velutina

Project description:Vespa velutina Genome sequencing

| PRJNA991255 | ENA

Michelia

Project description:Michelia( Michelia crassipes, Michelia crassipes variant clone, HuaHaoYueYuan, Michelia figo) Transcriptome

| PRJNA1080327 | ENA

Gleditsia japonica var. velutina

Project description:Gleditsia japonica var. velutina Genome sequencing and assembly

| PRJNA897082 | ENA

Armatimonadetes bacterium DC isolate:DC

Project description:Armatimonadetes bacterium DC isolate:DC Genome sequencing and assembly

| PRJNA285316 | ENA

Magnolia crassipes

Project description:Michelia crassipes Transcriptome sequencing

| PRJNA646857 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Genome skimming of Michelia macclurei

| PRJNA776621 | ENA